Cargando…
Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence
The purpose of this review is to assess whether dietary fish oil supplements can be appropriate for patients with elevated triglycerides and cardiovascular risk based on a comprehensive analysis of their composition, and level of regulatory oversight. RECENT FINDINGS: Approximately 19 million people...
Autores principales: | Sherratt, Samuel C.R., Lero, Michael, Mason, R. Preston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069411/ https://www.ncbi.nlm.nih.gov/pubmed/32022752 http://dx.doi.org/10.1097/MOL.0000000000000665 |
Ejemplares similares
-
The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives
por: Cupido, Arjen J., et al.
Publicado: (2021) -
DNA methylation in human lipid metabolism and related diseases
por: Mittelstraß, Kirstin, et al.
Publicado: (2018) -
Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2
por: Mulvihill, Erin E.
Publicado: (2018) -
The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case
por: Wand, Hannah, et al.
Publicado: (2021) -
CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis
por: Glatz, Jan F.C., et al.
Publicado: (2022)